Efficacy of Oral Chinese Medicine in Regulating the Intestinal Flora of Patients with Chronic Heart Failure: A Meta-Analysis.
Key findingA total of 18 clinical randomized controlled trial studies were included, with a total of 1,455 patients with chronic heart failure, including 731 in the trial group and 724 in the control group. The combination of oral Chinese medicine and conventional treatment had a better effective rate of cardiac function improvement than conventional Western medicine treatment alone.
POPULATION & DESIGNThis meta-analysis was registered with registration number: INPLASY202610010. PubMed, Embase, The Cochrane Library, Web of Science, China Biomedical Literature Database (CBM), China Journal Full Text Database (CNKI), Wanfang Database, and Wipu Database were searched by computer, while domestic and international orthopedic journals were searched manually. Clinical randomized controlled trials related to oral TCM containing danshen and rhubarb in combination with conventional Western medicines for the treatment of chronic heart failure that have been published in the public domain up to July 2024 were collected.
POTENTIAL CLINICAL IMPACTOral preparations containing danshen and rhubarb components of TCM combined with conventional methods for the treatment of chronic heart failure can regulate the intestinal flora of patients. Confirm applicability and limitations in the full paper before changing UK practice.
